tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IN:SUNPHARMA Stock Latest News

Sun Pharma’s GL0034 Diabetes Trial: Early-Stage Data Catalyst in a Crowded Metabolic Market
Company AnnouncementsSun Pharma’s GL0034 Diabetes Trial: Early-Stage Data Catalyst in a Crowded Metabolic Market
13d ago
Sun Pharma Advances GL0034 Diabetes Program With Kidney Function Study, Supporting Long-Term Pipeline Story
PremiumCompany Announcements
Sun Pharma Advances GL0034 Diabetes Program With Kidney Function Study, Supporting Long-Term Pipeline Story
20d ago
Sun Pharma Publishes Q3 FY26 Unaudited Results Notice in Newspapers
PremiumCompany Announcements
Sun Pharma Publishes Q3 FY26 Unaudited Results Notice in Newspapers
24d ago
Sun Pharma’s INSPIRE 1 Psoriatic Arthritis Trial Nears Key Data Milestone
PremiumCompany Announcements
Sun Pharma’s INSPIRE 1 Psoriatic Arthritis Trial Nears Key Data Milestone
1M ago
Sun Pharma Rolls Out UNLOXCYT in U.S. for Advanced Skin Cancer Patients
PremiumCompany Announcements
Sun Pharma Rolls Out UNLOXCYT in U.S. for Advanced Skin Cancer Patients
1M ago
Sun Pharma’s Baska Facility Receives OAI Classification from US FDA
PremiumCompany AnnouncementsSun Pharma’s Baska Facility Receives OAI Classification from US FDA
2M ago
Sun Pharma to Invest INR 3,000 Crores in New Manufacturing Facility
Premium
Company Announcements
Sun Pharma to Invest INR 3,000 Crores in New Manufacturing Facility
3M ago
Sun Pharma’s New Study on Actinic Keratosis Treatment: What Investors Need to Know
Premium
Company Announcements
Sun Pharma’s New Study on Actinic Keratosis Treatment: What Investors Need to Know
4M ago
Sun Pharma’s New Clinical Trial: A Potential Game-Changer for Actinic Keratosis Treatment
PremiumCompany Announcements
Sun Pharma’s New Clinical Trial: A Potential Game-Changer for Actinic Keratosis Treatment
4M ago
Sun Pharma’s Alopecia Areata Study: A Potential Game Changer?
PremiumCompany Announcements
Sun Pharma’s Alopecia Areata Study: A Potential Game Changer?
4M ago
Sun Pharma’s Composite Scheme of Arrangement Approved by NCLT
PremiumCompany Announcements
Sun Pharma’s Composite Scheme of Arrangement Approved by NCLT
5M ago
Sun Pharma’s Sonidegib Study Completion: A Boost for Oncology Market Presence
PremiumCompany Announcements
Sun Pharma’s Sonidegib Study Completion: A Boost for Oncology Market Presence
5M ago
Sun Pharma’s Halol Facility Faces FDA Compliance Challenges
PremiumCompany AnnouncementsSun Pharma’s Halol Facility Faces FDA Compliance Challenges
6M ago
Sun Pharma Announces Q1 Financials and Board Restructuring
Premium
Company Announcements
Sun Pharma Announces Q1 Financials and Board Restructuring
7M ago
Sun Pharma’s New Study on Tildrakizumab: A Potential Game Changer for Genital Psoriasis
Premium
Company Announcements
Sun Pharma’s New Study on Tildrakizumab: A Potential Game Changer for Genital Psoriasis
7M ago
Sun Pharma’s Promising Phase 3 Study on Genital Psoriasis Treatment
PremiumCompany Announcements
Sun Pharma’s Promising Phase 3 Study on Genital Psoriasis Treatment
7M ago
Sun Pharma’s Tildrakizumab Study: A Promising Step in Genital Psoriasis Treatment
PremiumCompany Announcements
Sun Pharma’s Tildrakizumab Study: A Promising Step in Genital Psoriasis Treatment
8M ago
Sun Pharma’s Promising Phase 3 Study on Tildrakizumab for Genital Psoriasis
PremiumCompany Announcements
Sun Pharma’s Promising Phase 3 Study on Tildrakizumab for Genital Psoriasis
8M ago
Sun Pharma’s Sonidegib Safety Study: Key Insights for Investors
PremiumCompany Announcements
Sun Pharma’s Sonidegib Safety Study: Key Insights for Investors
8M ago
Sun Pharma’s Tildrakizumab Study: A Potential Game-Changer for Psoriatic Arthritis
PremiumCompany AnnouncementsSun Pharma’s Tildrakizumab Study: A Potential Game-Changer for Psoriatic Arthritis
8M ago
Sun Pharma’s Tildrakizumab Study: A Potential Game-Changer for Psoriatic Arthritis Treatment
Premium
Company Announcements
Sun Pharma’s Tildrakizumab Study: A Potential Game-Changer for Psoriatic Arthritis Treatment
8M ago
Philogen Withdraws Nidlegy™ Application, Plans Resubmission
Premium
Company Announcements
Philogen Withdraws Nidlegy™ Application, Plans Resubmission
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >